We are live on ! Find out more
GJIC

Gamble Jones Investment Counsel Portfolio holdings

AUM $1.33B
1-Year Est. Return 11.55%
This Fund
S&P 500
This Quarter Est. Return
+3.19%
1 Year Est. Return
-11.55%
3 Year Est. Return
+32.88%
5 Year Est. Return
+72.75%
10 Year Est. Return
AUM
$918M
AUM Growth
+$17.9M
Cap. Flow
-$6.57M
Cap. Flow %
-0.72%
Top 10 Hldgs %
48.72%
Holding
210
New
7
Increased
65
Reduced
104
Closed
4

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$3.49M
2
DLTR icon
Dollar Tree
DLTR
+$2.16M
3
AAPL icon
Apple
AAPL
+$2.04M
4
PG icon
Procter & Gamble
PG
+$1.57M
5
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$1.24M

Sector Composition

Rank Sector Weight
1 Consumer Staples 37.54%
2 Healthcare 13.29%
3 Technology 9.66%
4 Industrials 9.01%
5 Financials 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EFA icon
201
iShares MSCI EAFE ETF
EFA
$80.2B
$215K 0.02%
3,857
-286
-7% -$16.5K
TEL icon
202
TE Connectivity
TEL
$62B
$211K 0.02%
3,700
-2,000
-35% -$120K
KKR icon
203
KKR & Co
KKR
$99.5B
$203K 0.02%
16,420
-5,126
-24% -$68.6K
EPD icon
204
Enterprise Products Partners
EPD
$81.9B
$202K 0.02%
+6,917
New +$186K
AZO icon
205
AutoZone
AZO
$49.7B
-259
Closed -$206K
CNQ icon
206
Canadian Natural Resources
CNQ
$98.1B
-19,612
Closed -$256K
CVS icon
207
CVS Health
CVS
$121B
-2,027
Closed -$210K
AGN
208
DELISTED
Allergan Inc
AGN
-1,300
Closed -$348K

Similar funds

Gamble Jones Investment Counsel's Q2 2016 Portfolio in Review

As of Q2 2016, Gamble Jones Investment Counsel held 210 positions worth $918M, up 2% from $900M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Gamble Jones Investment Counsel's Q2 2016 filing shows 7 new, 65 increased, 104 reduced and 4 closed positions. Its largest new stake was SS&C Technologies: 57,912 shares worth $1.63M. The largest sale was AbbVie, an estimated $3.49M.

By sector, the portfolio is most concentrated in Consumer Staples at 38% of assets, up from 37% a quarter earlier, followed by Healthcare and Technology.

  • Gamble Jones Investment Counsel's largest Q2 2016 buy was SS&C Technologies: 57,912 shares worth $1.63M.
  • Gamble Jones Investment Counsel added most to Novartis in Q2 2016, an estimated $3.76M increase.
  • Gamble Jones Investment Counsel's biggest Q2 2016 reduction was AbbVie, cutting an estimated $3.49M.
  • Gamble Jones Investment Counsel fully exited Allergan Inc in Q2 2016, selling an estimated $348K.
  • Gamble Jones Investment Counsel's ten largest holdings make up 49% of its $918M portfolio in Q2 2016.
  • Gamble Jones Investment Counsel opened 7 new positions and closed 4 in Q2 2016.
  • Gamble Jones Investment Counsel's portfolio value rose 2% quarter-over-quarter to $918M.

Based on Gamble Jones Investment Counsel's 13F filing for Q2 2016, filed 9 Aug 2016.